Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
Prevymis (letermovir) - Merck (MSD)
Clinical Outcome differences in Kidney Transplant Patients Receiving Letermovir Versus Valganciclovir for CMV Prophylaxis (IDWeek 2025) - Sep 3, 2025 - Abstract #P-2108; Pres time: Oct 22, 2025; 12:15 PM - 01:30 PM; Location: Poster Hall B4-B5; No abstract available 
Clinical • Clinical data • Infectious Disease
https://idweek2025.eventscribe.net/fsPopup.asp?PosterID=760070&mode=posterInfo
 
YoungYoon Ham, PharmD (she/her/hers); Ali Olyaei, PharmD; Ismael Aguirre, PharmD
 
Sep 3, 2025
 
Prev Next